OTC · Asset Management

Regent Pacific Group Limited (RPGLF) Stock

$0.01 +0.00% OTC: RPGLF Healthcare

Regent Pacific Group Limited operates as an investment holding company, directing capital towards businesses within the healthcare and life sciences sectors, primarily in European and Taiwanese markets. The company's activities are organized into two primary divisions: Biopharma and Corporate Investment.

Valuation

MetricValue
Price$0.01
Market Cap$1.72M
P/E Ratio-6.76
P/B Ratio-5.42
P/S Ratio98.90
EPS (TTM)$-0.02
52-Week High$0.43
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE87.15%
ROA-824.98%
ROCE128.50%
Gross Margin-115.70%
Operating Margin-1813.49%
Net Margin0.00%
Debt/Equity-0.59
Current Ratio0.07

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.0M$0$0$1.0M$0
Operating Profit$-14.0M$-35.0M$-30.0M$-4.0M$-4.0M
Net Profit$-13.0M$-36.0M$-25.0M$-4.0M$-5.0M
EPS$-0.10$-0.30$-0.11$-0.02$-0.02
Op Margin-426.3%-30697.4%-7953.7%-603.2%-1239.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$62.0M$26.0M$3.0M$1.0M$1.0M
Total Liabilities$23.0M$24.0M$4.0M$7.0M$7.0M
Cash$1.0M$0$2.0M$0$0
Borrowings$14.0M$14.0M$1.0M$3.0M$4.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$1.0M$-4.0M$-4.0M$-4.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$-1.0M$0$0$0$0
Net Cash Flow$-2.0M$0$2.0M$-2.0M$0
Free Cash Flow$-2.0M$1.0M$-4.0M$-4.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.02
EV / EBITDA-9.25
FCF Yield-12.03%
Quick Ratio0.07
Interest Coverage-11.71
Return 1Y742.86%
Return 3Y18.00%
Return 5Y—

Ownership

Insiders Held68.46%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPTAll American Pet Company, Inc. $0.00 — -0.02 $172870 0.00%
CNHCChina Health Management Corp. $0.00 — 8.75 $284011 0.00%
FRCBFirst Republic Bank $0.00 — 0.00 $74487 0.00%
LVGILimitless Venture Group Inc. $0.00 — 0.50 $288607 0.00%
OOGIC2E Energy, Inc. $0.00 — -0.50 $199465 0.00%

About Regent Pacific Group Limited

Regent Pacific Group Limited operates as an investment holding company, directing capital towards businesses within the healthcare and life sciences sectors, primarily in European and Taiwanese markets. The company's activities are organized into two primary divisions: Biopharma and Corporate Investment. Within the Biopharma segment, the focus is on the entire lifecycle of pharmaceutical products, from initial research and development to manufacturing, marketing, and sales, specifically addressing treatments for urological conditions. This division is also involved in developing advanced artificial intelligence systems engineered to quantify the aging rate across molecular, cellular, tissue, organ, systemic, physiological, and psychological aspects. The Corporate Investment division, meanwhile, commits funds to both publicly traded and privately owned entities. Additionally, the company offers various management services.

Regent Pacific Group Limited is headquartered in HK.

Regent Pacific Group Limited (RPGLF) stock trades at $0.01 with a market capitalization of $1.72M. The stock is valued at a price-to-earnings (P/E) ratio of -6.76, price-to-book of -5.42, price-to-sales of 98.90. Over the past 52 weeks the stock has ranged between $0.00 and $0.43, and currently trades 97.7% below its 52-week high.

On profitability, Regent Pacific Group Limited generates a return on equity (ROE) of 87.15% — well above the market average, a sign of a high-quality business, return on capital employed of 128.50%, an operating margin of -1813.49%, a net profit margin of 0.00%.

Official website: www.regentpac.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides